LOWERING CHOLESTEROL FOR PREVENTION OF CORONARY HEART-DISEASE - PROBLEMS AND PERSPECTIVES

被引:3
作者
OLIVER, MF
机构
[1] National Heart and Lung Institute, London, SW3 6LY, Dovehouse Street
关键词
HYPERCHOLESTEROLEMIA; TREATMENT; WOMEN; ALL CAUSE MORTALITY; FUTURE POLICIES;
D O I
10.1007/BF00878931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The evidence for aggressive treatment of severe hypercholesterolemia in men in order to reduce the development on a primary basis of the incidence of coronary heart disease is strong; the main benefit is reduction of morbidity. Extrapolation to women or to the management of mild hypercholesterolemia in either gender is not supported by facts. The value of reducing hypercholesterolemia in the young and in the elderly has not been tested. None of the primary or secondary prevention trials have reduced all-cause mortality. There is an inverse relation between cholesterol levels and noncardiovascular disease. The possibility that reducing mild to moderate elevation of cholesterol might be harmful to some people remains unanswered.
引用
收藏
页码:785 / 788
页数:4
相关论文
共 18 条
  • [1] CHOLESTEROL AND TOTAL MORTALITY - NEED FOR LARGER TRIALS
    COLLINS, R
    KEECH, A
    PETO, R
    SLEIGHT, P
    KJEKSHUS, J
    WILHELMSEN, L
    MACMAHON, S
    SHAW, J
    SIMES, J
    BRAUNWALD, E
    BURING, J
    HENNEKENS, C
    PFEFFER, M
    SACKS, F
    PROBSTFIELD, J
    YUSUF, S
    DOWNS, JR
    GOTTO, A
    COBBE, S
    FORD, I
    SHEPHERD, J
    [J]. BRITISH MEDICAL JOURNAL, 1992, 304 (6843) : 1689 - 1689
  • [2] COWEN PJ, 1992, BNF NUTR B, V17, P167
  • [3] WILL LOWERING POPULATION-LEVELS OF SERUM-CHOLESTEROL AFFECT TOTAL MORTALITY - EXPECTATIONS FROM THE HONOLULU-HEART-PROGRAM
    FRANK, JW
    REED, DM
    GROVE, JS
    BENFANTE, R
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (04) : 333 - 346
  • [4] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE
    FRICK, MH
    ELO, O
    HAAPA, K
    HEINONEN, OP
    HEINSALMI, P
    HELO, P
    HUTTUNEN, JK
    KAITANIEMI, P
    KOSKINEN, P
    MANNINEN, V
    MAENPAA, H
    MALKONEN, M
    MANTTARI, M
    NOROLA, S
    PASTERNACK, A
    PIKKARAINEN, J
    ROMO, M
    SJOBLOM, T
    NIKKILA, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245
  • [5] HOLME I, 1993, BRIT HEART J, V69, pS42
  • [6] HEALTH-POLICY ON BLOOD CHOLESTEROL - TIME TO CHANGE DIRECTIONS
    HULLEY, SB
    WALSH, JMB
    NEWMAN, TB
    [J]. CIRCULATION, 1992, 86 (03) : 1026 - 1029
  • [7] REPORT OF THE CONFERENCE ON LOW BLOOD CHOLESTEROL - MORTALITY ASSOCIATIONS
    JACOBS, D
    BLACKBURN, H
    HIGGINS, M
    REED, D
    ISO, H
    MCMILLAN, G
    NEATON, J
    NELSON, J
    POTTER, J
    RIFKIND, B
    ROSSOUW, J
    SHEKELLE, R
    YUSUF, S
    [J]. CIRCULATION, 1992, 86 (03) : 1046 - 1060
  • [8] LOW SERUM-CHOLESTEROL CONCENTRATION AND SHORT-TERM MORTALITY FROM INJURIES IN MEN AND WOMEN
    LINDBERG, G
    RASTAM, L
    GULLBERG, B
    EKLUND, GA
    [J]. BRITISH MEDICAL JOURNAL, 1992, 305 (6848) : 277 - 279
  • [9] MARTIN MJ, 1986, LANCET, V2, P933
  • [10] LOWERING CHOLESTEROL CONCENTRATIONS AND MORTALITY - A QUANTITATIVE REVIEW OF PRIMARY PREVENTION TRIALS
    MULDOON, MF
    MANUCK, SB
    MATTHEWS, KA
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1990, 301 (6747): : 309 - 314